Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters

World Journal of Gastroenterology

Volumn 9, Issue 11, 2003, Pages 2574-2578

  Lu, Lun Gen ^a   Zeng, Min De ^a   Wan, Mo Bin ^b   Li, Cheng Zhong ^b   Mao, Yi Min ^a   Li, Ji Qiang ^a   Qiu, De Kai ^a   Cao, Ai Ping ^a   Ye, Jun ^c   Cai, Xiong ^d   Chen, Cheng Wei ^e   Wang, Ji Yao ^f   Wu, Shan Ming ^g   Zhu, Jin Shui ^h   Zhou, Xia Qiu ⁱ  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Shanghai Putuo District Central Hospital   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e Nanjing Military Command   (China)

^f ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^g Shanghai Institute of Infectious Disease and Biosecurity   (China)

^h Shanghai No 6 Hospital   (China)

ⁱ SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA 2 MACROGLOBULIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; COLLAGEN TYPE 4; COLLAGEN TYPE 4 7S; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ANALYTICAL PARAMETERS; ARTICLE; B SCAN; CHRONIC LIVER DISEASE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ERYTHROCYTE COUNT; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN BLOOD FLOW; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; STAGING; THROMBOCYTE COUNT;

EID: 0344036236     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i11.2574     Document Type: Article

References (38)

1. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: A European study. Gut 2003; 52: 134-139
2. Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, Xu L, Eng F, Afdhal N, Kalluri R. Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003; 124: 147-159
3. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, Gallois Y, Rifflet H, Maiga MY, Penneau-Fontbonne D, Cales P. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113: 1609-1116
4. Guechot J, Serfaty L, Bonnand AM, Chazouilleres O, Poupon RE, Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 2000; 32: 447-452
5. Hayasaka A, Saisho H. Serum markers as tools to monitor liver fibrosis. Digestion 1998; 59: 381-384
6. Ninomiya T, Yoon S, Hayashi Y, Sugano M, Kumon Y, Seo Y, Shimizu K, Kasuga M. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: Histological evaluation by a modified histological activity index scoring system. J Gastroenterol Hepatol 1998; 13: 68-74
7. George DK, Ramm GA, Walker NI, Powell LW, Crawford DH. Elevated serum type IV collagen: A sensitive indicator of the presence of cirrhosis in haemochromatosis. J Hepatol 1999; 31: 47-52
8. Murawaki Y, Koda M, Okamoto K, Mimura K, Kawasaki H. Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C. J Gastroenterol Hepatol 2001; 16: 777-781
9. Wang T, Wang B, Liu X. Correlation of serum markers with fibrosis staging in chronic viral hepatitis. Zhonghua Binglixue Zazhi 1998; 27: 185-190
10. Zheng M, Cai W, Weng H, Liu R. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance. Chin Med J 2003; 116: 346-349
11. McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, Tong MJ. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000; 15: 945-951
12. Gabrielli GB, Capra F, Casaril M, Squarzoni S, Tognella P, Dagradi R, De Maria E, Colombari R, Corrocher R, De Sandre G. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis. Clin Chim Acta 1997; 265: 21-31
13. Castera L, Hartmann DJ, Chapel F, Guettier C, Mall F, Lons T, Richardet JP, Grimbert S, Morassi O, Beaugrand M, Trinchet JC. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis. J Hepatol 2000; 32: 412-418
14. Stickel F, Urbaschek R, Schuppan D, Poeschl G, Oesterling C, Conradt C, McCuskey RS, Simanowski UA, Seitz HK. Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease Dig Dis Sci 2001; 46: 2025-2032
15. Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H, Maiga MY, Gallois Y, Cales P. Histopathological evaluation of liver fibrosis: Quantitative image analysis vs semi-quantitative scores. Comparison with serum markers. J Hepatol 1998; 28: 439-446
16. Persico M, Palmentieri B, Vecchione R, Torella R, De SI. Diagnosis of chronic liver disease: Reproducibility and validation of liver biopsy. Am J Gastroenterol 2002; 97: 491-492
17. Wachsberg RH, Bahramipour P, Sofocleous CT, Barone A. Hepatofugal flow in the portan venous system: Pathophysiology, imaging findings, and diagnostic pitfalls. Radiographics 2002; 22: 123-140
18. Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D. Severe liver fibrosis or cirrhosis: Accuracy of US for detection-analysis of 300 cases. Radiology 2003; 227: 89-94
19. Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC, Guzman-Granier E, Chevallier P, Tran C, Longo F, Schneider S, Piche T, Hebuterne X, Benzaken S, Rampal P. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol 2000; 24: 626-630
20. Aube C, Oberti F, Korali N, Namour MA, Loisel D, Tanguy JY, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Rifflet H, Maiga MY, Penneau-Fontbonne D, Caron C, Cales P. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999; 30: 472-478
21. Murakami T, Mochizuki K, Nakamura H. Imaging evaluation of the cirrhotic liver. Semin Liver Dis 2001; 21: 213-224
22. Laghi A, Iannaccone R, Catalano C, Carbone I, Ferrari R, Mangiapane F, Passariello R. Multiphase multislice spiral CT for liver assessment: Optimization in cirrhotic patients. Radiol Med 2002; 103: 188-195
23. Bernatik T, Strobel D, Hahn EG, Becker D. Doppler measurements: A surrogate marker of liver fibrosis? Eur J Gastroenterol Hepatol 2002; 14: 383-387
24. Martinez-Noguera A, Montserrat E, Torrubia S, Villalba J. Doppler in hepatic cirrhosis and chronic hepatitis. Semin Ultrasound CT MR 2002; 23: 19-36
25. Kok T, van der Jagt EJ, Haagsma EB, Bijleveld CM, Jansen PL, Boeve WJ. The value of Doppler ultrasound in cirrhosis and portal hypertension. Scand J Gastroenterol Suppl 1999; 230: 82-88
26. Lonjedo E, Ripolles T. Vascular imaging and interventional procedures in hepatic cirrhosis. Semin Ultrasound CT MR 2002; 23: 130-140
27. Thabut D, Simon M, Myers RP, Messous D, Thibault V, Imbert-Bismut F, Poynard T. Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology 2003; 37: 1220-1221
28. Myers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T. Biochemical markers of liver fibrosis: A comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol 2002; 97: 2419-2425
29. Prevention and treatment projects of virus hepatitis (tryout). Chin J Intern Med 1995; 34: 788-791
30. Flisiak R, Maxwell P, Prokopowicz D, Timms PM, Panasiuk A. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1-possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis. Hepatogastroenterology 2002; 49: 1369-1372
31. Murawaki Y, Nishimura Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H. Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis. J Gastroenterol Hepatol 1998; 13: 680-684
32. Walsh KM, Timms P, Campbell S, MacSween RN, Morris AJ. Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: Comparison using ROC analysis. Dig Dis Sci 1999; 44: 624-630
33. Kanzler S, Baumann M, Schirmacher P, Dries V, Bayer E, Gerken G, Dienes HP, Lohse AW. Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat 2001; 8: 430-437
34. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 2001; 96: 3142-3146
35. Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa P, Testa R. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003; 163: 218-224
36. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat 1998; 5: 187-192
37. Zheng M, Cai WM, Weng HL, Liu RH. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. World J Gastroenterol 2002; 8: 1073-1076
38. Chen YP, Feng XR, Dai L, Ding HB, Zhang L. Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B. Zhonghua Ganzangbing Zazhi 2003; 11: 225-227